Liu C - Search Results

1

WITHDRAWN: Skullcapflavone I has a potent anti-pancreatic cancer activity by targeting miR-23a.

Cui J, Li H, Wang Y, Tian T, Liu C, Wang Y, Sun S, Feng B. Cui J, et al. Among authors: liu c. Life Sci. 2019 May 11:S0024-3205(19)30371-6. doi: 10.1016/j.lfs.2019.05.025. Online ahead of print. Life Sci. 2019. PMID: 31085241

2

Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.

Cui J, Yu Y, Lu GF, Liu C, Liu X, Xu YX, Zheng PY. Cui J, et al. Among authors: liu x, liu c. Tumour Biol. 2013 Jun;34(3):1913-8. doi: 10.1007/s13277-013-0735-x. Epub 2013 Mar 21. Tumour Biol. 2013. PMID: 23516026

3

Investigation of miRNA- and lncRNA-mediated competing endogenous RNA network in cholangiocarcinoma.

He Y, Liu C, Song P, Pang Z, Mo Z, Huang C, Yan T, Sun M, Fa X. He Y, et al. Among authors: liu c. Oncol Lett. 2019 Nov;18(5):5283-5293. doi: 10.3892/ol.2019.10852. Epub 2019 Sep 12. Oncol Lett. 2019. PMID: 31612038 Free PMC article.

4

Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines.

Wang S, Liu C, Liu X, He Y, Shen D, Luo Q, Dong Y, Dong H, Pang Z. Wang S, et al. Among authors: liu x, liu c. Tumour Biol. 2017 Oct;39(10):1010428317718192. doi: 10.1177/1010428317718192. Tumour Biol. 2017. PMID: 29034777 Free article.

5

Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.

He J, Lv P, Yang X, Chen Y, Liu C, Qiu X. He J, et al. Among authors: liu c. Tumour Biol. 2016 Jul;37(7):9037-43. doi: 10.1007/s13277-016-4793-8. Epub 2016 Jan 13. Tumour Biol. 2016. PMID: 26762408

6

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.

Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng Q, Luo P, Liu G. Zhang H, et al. Among authors: liu z, liu c, liu g. Mol Cancer. 2023 Oct 2;22(1):159. doi: 10.1186/s12943-023-01860-5. Mol Cancer. 2023. PMID: 37784082 Free PMC article. Review.

7

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling.

Nie Y, Liu C, Liu Q, Zhu X. Nie Y, et al. Among authors: liu c, liu q. BMC Cancer. 2023 Feb 13;23(1):150. doi: 10.1186/s12885-023-10615-w. BMC Cancer. 2023. PMID: 36782176 Free PMC article.

8

Deciphering the Role of SLFN12: A Novel Biomarker for Predicting Immunotherapy Outcomes in Glioma Patients Through Artificial Intelligence.

Chen Z, Liu C, Zheng W, Fang Y, Zhang H, Luo J, Li J, Qiu Y, Peng J, Xia Y, Miao C, Luo Q. Chen Z, et al. Among authors: liu c. J Cell Mol Med. 2024 Dec;28(24):e70317. doi: 10.1111/jcmm.70317. J Cell Mol Med. 2024. PMID: 39740094 Free PMC article.

9

Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas.

Chen Z, Liu C, Zhang C, Xia Y, Peng J, Miao C, Luo Q. Chen Z, et al. Among authors: liu c. Front Immunol. 2024 Sep 24;15:1475206. doi: 10.3389/fimmu.2024.1475206. eCollection 2024. Front Immunol. 2024. PMID: 39380997 Free PMC article.

10

Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness.

Li X, Li P, Liu C, Ren Y, Tang X, Wang K, He J. Li X, et al. Among authors: liu c. Oncotarget. 2017 Feb 21;8(8):13560-13574. doi: 10.18632/oncotarget.14593. Oncotarget. 2017. PMID: 28088791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79,628 results

Search Page

Filters